Saltar al contenido
Global sound
Tick Boot Camp

Tick Boot Camp

Episode 628: Can Ozempic Help MCAS and Chronic Lyme? Dr. Tania Dempsey's New Research | LIVE from ILADS

· 17 min · Temporada 1 Episodio 628

Notas del episodio

Could medications best known for weight loss and diabetes offer a new way to manage mast cell activation syndrome (MCAS), inflammation, and symptoms experienced by some patients with chronic Lyme disease?

In this LIVE from ILADS episode of the Tick Boot Camp Podcast, co-host Rich Johannesen reunites with Dr. Tania Dempsey, MD, a physician specializing in complex chronic illness, mast cell activation syndrome, and tick-borne diseases, for an exciting discussion about emerging research into GLP-1 medications and immune system dysfunction.

Recorded at the 2025 International Lyme and Associated Diseases Society (ILADS) Conference in San Antonio, Texas, the conversation centers on Dr. Dempsey's recently published research investigating GLP-1 receptor agonists—medications such as Ozempic, Wegovy, Mounjaro, and Zepbound—as potential treatments for patients with MCAS.

Dr. Dempsey discusses a 47-patient case series in which 87% of participants reportedly experienced a positive response to GLP-1-based treatment. She explains why these medications may have effects beyond blood sugar regulation and weight management, including potential influences on mast cell activity and inflammation.

The interview also explores how mast cell dysfunction may interact with other components of the immune system, why Dr. Dempsey questions relying exclusively on antibody testing when evaluating certain complex patients, and how emerging molecular diagnostic methods could influence the future of tick-borne disease care.

Throughout the conversation, Dr. Dempsey emphasizes the importance of individualized treatment, continuing research, and helping both patients and healthcare professionals better understand complicated chronic illnesses.

Could GLP-1 medications represent a new direction in MCAS research? And what might that mean for patients living with Lyme disease, Bartonella, and overlapping inflammatory symptoms?

This episode explores those questions while distinguishing promising early clinical observations from treatments that have been conclusively established through larger controlled studies.

Meet Dr. Tania Dempsey, MD: MCAS and Complex Chronic Illness

Dr. Tania Dempsey is a physician known for her clinical work with patients experiencing mast cell activation syndrome, Lyme disease, tick-borne infections, and other complex chronic conditions.

Her interests include the relationship between immune system dysfunction, inflammation, environmental exposures, and persistent symptoms.

Dr. Dempsey has become an increasingly prominent voice in discussions about MCAS and its potential relationship with other chronic illnesses.

During this interview, she shares how appearing on major podcasts, including Dave Asprey's podcast, has helped her reach a broader audience.

She explains that although she loves working directly with patients, her larger mission is to share information with healthcare professionals and patients around the world.

Dr. Dempsey also discusses…

Web: podcast.tickbootcamp.com

En directo, última hora: 7.530 canciones en 3.234 emisoras de 114 países

Descubre el mundo a través de la radio

Más formas de descubrir (7)

¿Has oído algo bueno? Guárdalo o ábrelo directamente en Spotify.

★ Artista de la semana El que más sube en la radio esta semana
¿Tu canción aquí? Desde € 9 por semana →
Pop Hits – WHFF RadioSeguir escuchando